Muhlenkamp & Co Inc Buys Equity Commonwealth, Sells Biogen Inc, Invitae Corp

Wexford, PA, based Investment company Muhlenkamp & Co Inc (Current Portfolio) buys Equity Commonwealth, sells Biogen Inc, Invitae Corp during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Muhlenkamp & Co Inc. As of 2021Q3, Muhlenkamp & Co Inc owns 33 stocks with a total value of $260 million. These are the details of the buys and sells.

For the details of Ronald Muhlenkamp's stock buys and sells, go to https://www.gurufocus.com/guru/ronald+muhlenkamp/current-portfolio/portfolio

These are the top 5 holdings of Ronald Muhlenkamp
  1. WESCO International Inc (WCC) - 130,575 shares, 5.78% of the total portfolio. Shares reduced by 0.17%
  2. Microchip Technology Inc (MCHP) - 189,822 shares, 5.59% of the total portfolio. Shares reduced by 0.19%
  3. Rush Enterprises Inc (RUSHA) - 317,711 shares, 5.51% of the total portfolio.
  4. McKesson Corp (MCK) - 65,548 shares, 5.02% of the total portfolio. Shares reduced by 0.13%
  5. Microsoft Corp (MSFT) - 44,701 shares, 4.84% of the total portfolio. Shares reduced by 0.17%
New Purchase: Equity Commonwealth (EQC)

Muhlenkamp & Co Inc initiated holding in Equity Commonwealth. The purchase prices were between $25.57 and $27.15, with an estimated average price of $26.31. The stock is now traded at around $25.229500. The impact to a portfolio due to this purchase was 1.13%. The holding were 112,943 shares as of 2021-09-30.

Sold Out: Biogen Inc (BIIB)

Muhlenkamp & Co Inc sold out a holding in Biogen Inc. The sale prices were between $282.99 and $369.05, with an estimated average price of $328.16.

Sold Out: Invitae Corp (NVTA)

Muhlenkamp & Co Inc sold out a holding in Invitae Corp. The sale prices were between $24.31 and $33.6, with an estimated average price of $29.39.



Here is the complete portfolio of Ronald Muhlenkamp. Also check out:

1. Ronald Muhlenkamp's Undervalued Stocks
2. Ronald Muhlenkamp's Top Growth Companies, and
3. Ronald Muhlenkamp's High Yield stocks
4. Stocks that Ronald Muhlenkamp keeps buying